Regeneron, a biotech company in the United States, has received approval for urgent use from the US Food and Drug Administration FDA.

According to foreign media such as Reuters and Bloomberg, on the 21st of the local time, the FDA approved the emergency use of Regeneron's monoclonal antibody treatment'REGN-COV2'.

(Photo = Getty Image Korea)